Mucosal leishmaniasis: In situ characterization of the host inflammatory response, before and after treatment

Acta Tropica

Volumn 85, Issue 1, 2003, Pages 39-49

  Amato, Valdir Sabbaga ^a,b   De Andrade Jr , Heitor Franco ^a   Seixas Duarte, Maria Irma ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Inst of Tropical Med of Sao Paulo ^*  (Brazil)

Author keywords

Immunohistochemistry; Mucocutaneous leishmaniasis; Mucosal leishmaniasis (ML); Treatment

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; COMPLEMENTARY DNA; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

HEALTH MONITORING; IMMUNITY; LEISHMANIASIS; PARASITE;

AMASTIGOTE; ARTICLE; CONTROLLED STUDY; HOST PARASITE INTERACTION; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLAMMATION; LEISHMANIA; LEISHMANIASIS; LYMPHOCYTE; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; REDUCTION; RISK FACTOR; SCAR FORMATION;

ADULT; AGED; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, SURFACE; ANTIPROTOZOAL AGENTS; CYTOKINES; FEMALE; HOST-PARASITE RELATIONS; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-4; LEISHMANIASIS, MUCOCUTANEOUS; MALE; PHENOTYPE; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037213994     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-706X(02)00260-7     Document Type: Article

References (34)

1. Amato V.S., Duarte M.I.S., Nicodemo A.C., Carvalho L.V., Pagliari C., Matta V.L.R., Oliveira L.S., Castro S.M., Uip D.E., Amato J.G.P., Amato Neto V. An evaluation of clinical, serologic, anatomopathologic and immunohistochemical findings for fifteen patients with mucosal leishmaniasis before and after treatment. Rev. Inst. Med. Trop. São Paulo. 40:1998;23-30.
2. Amato V.S., Padilha A.R., Nicodemo A.C., Duarte M.I., Valentini M., Uip D.E., Boulos M., Neto V.A. Use of itraconazole in the treatment of mucocutaneous leishmaniasis: a pilot study. Int. J. Infect. Dis. 4:2000;153-157.
3. Barral A., Barral-Netto M., Young E.C., Brownell C.E., Twardzik D.R., Reed S.G. Transforming growth factor β as a virulence mechanism for Leishmania braziliensis. Proc. Natl. Acad. Sci. USA. 90:1993;3442-3446.
4. Barral A., Jesus A.R., Almeida R.P., Carvalho E.M., Barral-Netto M., Costa J.M., Badaro R., Rocha H., Johnson W.D. Evaluation of T-cell subsets in the lesion infiltrates of human cutaneous and mucocutaneous leishmaniasis. Parasitol. Immunol. 9:1987;487-497.
5. Barral-Netto M., Brodskyn C., Carvalho E.M., Barral A. Human_leishmaniasis cytoquine.bahia.br. Braz. J. Med. Biol. Res. 31:1998;149-155.
6. Berman J.D. Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin. Infect. Dis. 24:1997;684-703.
7. Beutler B., Cerami A. The biology of cachectin/TNF-a primary mediator of the host response. Ann. Rev. Immunol. 7:1989;625-655.
8. Botelho A.C.C., Tafuri W.L., Genaro O., Mayrink W. Histopathology of human American cutaneous Leishmaniasis before and after treatment. Rev. Soc. Bras. Med. Trop. 31:1998;11-18.
9. Carvalho E.M., Johnson W.D., Barreto E., Marsden P.D., Costa J.L., Reed S., Rocha H. Cell mediated immunity in American cutaneous and mucosal leishmaniasis. J. Immunol. 135:1985;4144-4148.
10. Cassatella M.A., Meda L., Bonora S., Ceska M., Constantin G. Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysaccharide. J. Exp. Med. 178:1993;2207-2211.
11. Da-Cruz A.M., Bittar R., Mattos M., Oliveira-Neto, Nogueira R., Pinho-Ribeiro V., Azeredo-Coutinho R.B., Coutinho S.G. T-Cell-mediated immune responses in patients with cutaneous or mucosal leishmaniasis; long-term evaluation after therapy. Clin. Diagn. Lab. Immunol. 9:2002;251-256.
12. Da-Cruz A.M., Oliveira M.P., De-Luca P.M., Mendonça S.C.F., Coutinho S.G. Tumor necrosis factor-α in human tegumentary leishmaniasis. Mem. Inst. Oswaldo Cruz. 91:1996;225-229.
13. De Waal M.R., Haanen J., Spits H., Roncarolo M.G., Te Velde A., Figdor C., Johnson K., Kastelein R., Yssel H., De Vries J.E. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 174:1991;915-924.
14. Esterre P., Dedet J.P., Frenay M., Chevallier M., Grimaud J.A. Cell populations in the lesion of human cutaneous leishmaniasis: a light microscopical, immunohistochemical and ultrastructural study. Virchows Arch. A Pathol. Anat. 421:1992;239-247.
15. Falcoff E., Taranto N.J., Remondegui D.E., Dedet J.P., Canini L.M., Ripoll C.M., Dimier-David L., Vargas F., Gimenez L.A., Bernarbo J.G. Clinical healing of antimony-resistant cutaneous or mucocutaneous leishmaniasis following the combined administration of interferon-γ and pentavalent antimonial compounds. Trans. R. Soc. Trop. Med. Hyg. 88:1994;95-97.
16. Franke E.D., Wignall S., Cruz M.E., Rosales E., Tovar A.A., Lucas C.M., Llanos-Cuentas A. Efficacy and toxicity of sodium stibogluconate for mucosal leishmaniasis. Ann. Intern. Med. 113:1990;934-940.
17. Grimaldi G. Jr, Tesh R.B., McMahon-Pratt D. A review of the geographic distribution and epidemiology of leishmaniasis in the new world. Am. J. Trop. Med. Hyg. 41:1989;687-725.
18. Hall B.F., Joiner K.A. Strategies of obligate intracellular parasites for evading host defences. Immunol. Today. 12:1991;22-27.
19. Jankovic D., Liu Z., Gause W. Th1-and-Th2-cell commitment during infectious disease: asymmetry in divergent pathways. Trends Immunol. 22:2001;450-457.
20. Marsden P.D. Mucosal leishmaniasis (espundia Escomel, 1911). Trans. R. Soc. Trop. Med. Hyg. 80:1986;859-876.
21. Mossmann T.R., Cherwinski H., Bond M.W., Giedlin M.A., Coffman R.L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:1986;2348-2357.
22. Muller I., Kropf P., Louis J.A., Milon G. Expansion of gamma interferon-producing CD8+ T cells following secondary infection of mice immune to Leishmania major. Infect. Immun. 62:1994;2575-2581.
23. Nonata R., Sampaio R., Marsden P.D. Mucosal leishmaniasis unresponsive to glucantime therapy successfully treated with AmBisome. Trans. R. Soc. Trop. Med. Hyg. 91:1997;7.
24. Okamura H., Kashiwamura S., Tsutsui H., Yoshimoto T., Nakanishi K. Regulation of interferon-gamma production by IL-12 and IL-18. Curr. Opin. Immunol. 10:1998;259-264.
25. Oliveira M.R.F., Macedo V.O., Carvalho E.M., Barral A., Marotti J.G., Bittencourt A., de Abreu M.V., Orge M.L.O., Lessa H.A., Marsden P.D. An evolutionary study of mucosal leishmaniasis (a 7- to 17-year follow-up) due to Leishmania (Viannia) braziliensis in Três Braços, Bahia. Rev. Soc. Bras. Med. Trop. 28:1995;325-332.
26. Pirmez C., Cooper C., Paes-Oliveira M., Schubach A., Torigian V.K., Modlin R.L. Immunologic responsiveness in American cutaneous leishmaniasis lesions. J. Immunol. 9:1990;3100-3104.
27. Pirmez C., Yamamura M., Uyemura K., Paes-Oliveira M., Conceição-Silva F., Modlin R.L. Cytokine patterns in the pathogenesis of human leishmaniasis. J. Clin. Invest. 91:1993;1390-1395.
28. Sands M., Kron M.A., Brown R.B. Pentamidine: a review. Rev. Infect. Dis. 7:1985;625-634.
29. Schubach A., Marzochi M.C.A., Cuzzi-Maya T., Oliveira A.V., Araujo M.L., Oliveira A.L.C., Pacheco R.S., Momen H., Conceição-Silva F., Coutinho S.G., Marzochi K.B.F. Cutaneous scars in American tegumentary leishmaniasis patients: a site of Leishmania (Viannia) braziliensis persistence and viability eleven years after antimonial theraphy and clinical cure. Am. J. Trop. Med. Hyg. 58:1998;824-827.
30. Schubach A., Haddad F., Paes-Oliveira Neto M., Degrave W., Pirmez C., Grimaldi G. Jr, Fernades O. Detection of Leishmania DNA by polimerase chain reaction in scars of treated human patients. J. Infect. Dis. 178:1998;911-914.
31. Silva T.M.C., Barral A., Pompeu M.M.L., Costa J., Lessa H., Carvalho E.M., Freitas L.A. In situ inflammatory-immune response in human tegumentary leishmaniasis: morphologic evidence for a pathogenic role of TNF-α Mem. Inst. Oswaldo Cruz. 93:(Suppl II):1998;49-50.
32. Singer C., Armstrong D., Jones T.C., Spiro R.H. Imported mucocutaneous leishmaniasis in New York City. Am. J. Med. 59:1975;444-447.
33. Titus R.G., Sherry B., Cerami A. Tumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis. J. Exp. Med. 1:1989;2097-2104.
34. Toledo V.P.C.P., Mayrink W., Gollob K.J., Oliveira M.A.P., Costa C.A., Genaro O., Pinto J.A., Afonso L.C.C. Mem. Inst. Oswaldo Cruz. 96:2001;89-98.